Objective: To estimate comprehensive cost of rheumatoid arthritis (RA) patients to society
and individual stakeholders, including patients/employees, employers, family members/…

Objective To estimate the excess risk of cardiovascular and cerebrovascular diseases
among individuals with ankylosing spondylitis (AS) in Quebec compared with the general …

Objective New classification criteria for axial spondyloarthritis (SpA) have been validated by
the Assessment of SpondyloArthritis international Society (ASAS) working group. We …

Objective: To evaluate the effects of adalimumab on patient-reported outcomes of joint-related
and skin-related functional impairment, health-related quality of life, fatigue and pain in …

Objectives Tumour necrosis factor inhibition plus methotrexate is believed to inhibit
radiographic progression independent of inflammation. This analysis assessed whether these …

Objective. Rheumatoid arthritis (RA) is associated with significant impairments in health-related
quality of life (HRQOL). We evaluated patient-reported outcomes including HRQOL …

OBJECTIVE: To compare the effect of adalimumab plus methotrexate (MTX) versus MTX
monotherapy on health-related quality of life (HRQOL) and work activities in patients with early …

Introduction Biologic therapies have demonstrated efficacy and safety in several chronic
systemic disorders. The authors indirectly compared response rates and costs per responder …

Objective The few published estimates of the risk of renal complications in ankylosing
spondylitis (AS) are established on clinic‐based studies. Our objective was to estimate the age‐ …

Objective To evaluate household and work place outcomes for patients with rheumatoid
arthritis (RA) who were homemakers or employed workers, respectively, and who were treated …